On April 29, 2026 BioInvent reported Interim Report January 1 – March 31, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Presentation, BioInvent, APR 29, 2026, https://www.bioinvent.com/sites/bioinvent/files/pr/20260429-51c9b5d9-2ceb-41f4-a239-3f96c510f570-1.pdf?ts=1777461002 [SID1234669185])